Evidence map›Paper›PMID 29204762›Full record

ArticleClinical rheumatology2018

Magnetic resonance imaging (MRI) of feet demonstrates subclinical inflammatory joint disease in cutaneous psoriasis patients without clinical arthritis.

Ashish J Mathew, Paul Bird, Ankan Gupta, Renu George, Debashish Danda

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04488185 (An Exploratory, Randomized, Double-blind, Parallel-group, Multicenter Study to Compare Secukinumab 300 mg With Placebo After 16 Weeks of Treatment in Adults With Moderate to Severe Plaque Psoriasis and Subclinical Enthesitis Measured by Musculoskeletal Ultrasound), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04488185 phase4withdrawnnot on this mapstarted 2020, after this paper: background citation

An Exploratory, Randomized, Double-blind, Parallel-group, Multicenter Study to Compare Secukinumab 300 mg With Placebo After 16 Weeks of Treatment in Adults With Moderate to Severe Plaque Psoriasis and Subclinical Enthesitis Measured by Musculoskeletal Ultrasound

TypeinterventionalSponsorNovartis PharmaceuticalsRan2020 to 2021Enrolled0ConditionsPsoriasisArmsSecukinumab 300 mg, Placebo
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Observational
  6. Article
  7. Review
  8. MRI of synovitis and joint fluid.Journal of magnetic resonance imaging : JMRI · 2019
    Review
  9. Article
  10. A new player in psoriatic arthritis: a JAK inhibitor.Mediterranean journal of rheumatology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ashish J MathewDepartment of Clinical Immunology & Rheumatology, Christian Medical College, Vellore, 632 004, India.
Paul BirdUniversity of NSW, Sydney, Australia.
Ankan GuptaDepartment of Dermatology, Christian Medical College, Vellore, India.
Renu GeorgeDepartment of Dermatology, Christian Medical College, Vellore, India.
Debashish DandaDepartment of Clinical Immunology & Rheumatology, Christian Medical College, Vellore, 632 004, India. debashisdandacmc@hotmail.com.
Christian Medical College & Hospital · IN

Funding

Asia Pacific League of Associations for Rheumatology Research Grant 2015Christian Medical College, Vellore IRB Fluid grant
6 · The paper itself

Abstract

We evaluated inflammation at the small joints of feet in psoriasis patients without clinical arthritis (PsO) as against clinically overt psoriatic arthritis (PsA) patients, using a low field magnet extremity MRI (eMRI). Patients with psoriasis recruited from dermatology and rheumatology clinics of a tertiary care institution in southern India were divided into PsO and PsA groups. Demographic and physical examination details were recorded. Consenting patients underwent non-contrast eMRI of the right foot. Two trained readers scored the MRI parameters of inflammation (synovitis, tenosynovitis, osteitis) using a modification of the PsA magnetic resonance imaging score (PsAMRIS). Proportion of patients with any sign of MRI inflammation was noted. Clinical variables were compared with inflammation scores for any association. A total of 83 patients (30 PsA and 53 PsO), with 75% males and mean age of 42.2 ± 11.6 years were included. There was no statistical difference between the median eMRI inflammatory scores in PsA and PsO patients (p = 0.493). Evidence of inflammation was present in 33.9% and 50% patients in the PsO and PsA groups, respectively. Early arthritis for psoriatic patients screening questionnaire (EARP) score of ≥ 3 was significantly associated with imaging features of inflammation in PsO group (p = 0.044). This study corroborates a high proportion of subclinical inflammation in small joints of foot in PsO patients, which needs to be reproduced in larger, longitudinal cohorts to predict risk factors for progression to future PsA development.

Indexed as

AdultArthritis, PsoriaticDisease ProgressionFemaleFootHumansInflammationMagnetic Resonance ImagingMaleMiddle AgedPsoriasisSeverity of Illness IndexInflammationMagnetic resonance imagingPsoriasisPsoriatic arthritis

Identifiers

PMID29204762
OpenAlexW2772007146

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.